2Ruschitzka F T,Nall G, Lascher T F. The endothellum in coronary artery disease. Cardiology, 1997,88 : 3-- 19.
3Rajagopalan S, Harrison D G. Reversing endothelial dysfuntion with ACE inhibitors: A new TREND? Circulation, 1996, 94:240--243.
4Rajagopalan S, Kurz S, Munzcl T, et al. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alternation of vasomotor tone. J Clin Invest, 1996,97 : 1916-- 1923.
5Harrison D G. Endothelial control of vasomotion and nitric oxide production. Cardiol Clin, 1996,14 : 1-- 15.
6Warnholtz A, Nickenig G, Schulz E, et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis:evidence for the involvement of the rennin-angiotensin system. Circulation,1999, 99:2027--2033.
7Vaughan D E. Fibrinolytic balance, the rennin-angiotensin system and atherosclerotic disease. Eur Heart J,1998,19 : G9-- G12.
8Nishimura H, Tsuji H. The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial calls. Thromb Haemostasis, 1999,82:1516--1521.
9Morawietz H, Rueckschloss U. Angiotensin II induces LOX- 1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation, 1999, 100:899 --902.
10Goodfield M B, Newby D E. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure. Circulation, 1999,99:2983--2985.
